21-45468376-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001379500.1(COL18A1):​c.241C>T​(p.Arg81Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,613,832 control chromosomes in the GnomAD database, including 58 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R81Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.010 ( 31 hom., cov: 34)
Exomes 𝑓: 0.0011 ( 27 hom. )

Consequence

COL18A1
NM_001379500.1 missense

Scores

6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.32

Publications

5 publications found
Variant links:
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL18A1 Gene-Disease associations (from GenCC):
  • Knobloch syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Knobloch syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
  • hereditary glaucoma, primary closed-angle
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005399853).
BP6
Variant 21-45468376-C-T is Benign according to our data. Variant chr21-45468376-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0102 (1549/152364) while in subpopulation AFR AF = 0.0346 (1439/41590). AF 95% confidence interval is 0.0331. There are 31 homozygotes in GnomAd4. There are 749 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 31 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL18A1NM_001379500.1 linkc.241C>T p.Arg81Trp missense_variant Exon 3 of 42 ENST00000651438.1 NP_001366429.1
COL18A1NM_130444.3 linkc.1486C>T p.Arg496Trp missense_variant Exon 2 of 41 NP_569711.2
COL18A1NM_030582.4 linkc.781C>T p.Arg261Trp missense_variant Exon 2 of 41 NP_085059.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL18A1ENST00000651438.1 linkc.241C>T p.Arg81Trp missense_variant Exon 3 of 42 NM_001379500.1 ENSP00000498485.1
COL18A1ENST00000355480.10 linkc.781C>T p.Arg261Trp missense_variant Exon 2 of 41 1 ENSP00000347665.5
COL18A1ENST00000359759.8 linkc.1486C>T p.Arg496Trp missense_variant Exon 2 of 41 5 ENSP00000352798.4

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1546
AN:
152246
Hom.:
31
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0346
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00556
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00243
AC:
607
AN:
249458
AF XY:
0.00178
show subpopulations
Gnomad AFR exome
AF:
0.0342
Gnomad AMR exome
AF:
0.00154
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000795
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00107
AC:
1563
AN:
1461468
Hom.:
27
Cov.:
35
AF XY:
0.000893
AC XY:
649
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.0371
AC:
1242
AN:
33480
American (AMR)
AF:
0.00197
AC:
88
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53002
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000486
AC:
54
AN:
1112010
Other (OTH)
AF:
0.00248
AC:
150
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
112
224
336
448
560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1549
AN:
152364
Hom.:
31
Cov.:
34
AF XY:
0.0101
AC XY:
749
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.0346
AC:
1439
AN:
41590
American (AMR)
AF:
0.00555
AC:
85
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68036
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
78
156
234
312
390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00227
Hom.:
5
Bravo
AF:
0.0116
ESP6500AA
AF:
0.0317
AC:
130
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.00301
AC:
364
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 25, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Dec 25, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Knobloch syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;.;T
Eigen
Uncertain
0.25
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.55
D
LIST_S2
Uncertain
0.90
D;D;D
MetaRNN
Benign
0.0054
T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.0
.;.;M
PhyloP100
2.3
PrimateAI
Benign
0.24
T
PROVEAN
Uncertain
-4.4
D;D;D
REVEL
Benign
0.15
Sift
Uncertain
0.0040
D;D;D
Sift4G
Uncertain
0.012
D;D;D
Vest4
0.52
ClinPred
0.022
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.23
gMVP
0.58
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76658745; hg19: chr21-46888290; COSMIC: COSV99051953; API